Danaher price target lowered to $265 from $285 at Citi

Citi lowered the firm’s price target on Danaher (DHR) to $265 from $285 and keeps a Buy rating on the shares post the Q4 report. The company guided below expectations, the analyst tells investors in a research note. The firm says that while management is typically conservative, the initial earnings outlook is lower than anticipated with a ramp throughout 2025, though it believes the bioprocessing guide has upside given consumables momentum.